Izra-L Capsule SR
Images are for reference. Actual packaging may vary.
1 units • OtherPrescription requiredSchedule H
Izra-L Capsule SR
Levosulpiride (75mg) + Esomeprazole (40mg)
₹291.50
1 units • Other
A valid prescription is required for this medicine.
1
Delivery
Safe & Secure
Easy Returns
24/7 Support
SMARTER CARE
A little guidance.
A better choice.
Haven’t found an alternative? A health advisor can help you understand what to do next.
No matching alternative found
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
Esomeprazole 40 mg
+1 more active ingredient
How It Works
Esomeprazole irreversibly inhibits the H+/K+ ATPase enzyme in the gastric parietal cells, reducing gastric acid secretion.
Medicine Strength
40 mg
All Active Ingredients
Esomeprazole40 mg
Levosulpiride75 mg
Uses & Benefits
Medical applications
HeadacheFluUlcerNausea
Izra-L Capsule SR is a combination pharmaceutical formulation containing Levosulpiride 75 mg and Esomeprazole 40 mg, designed for the management of gastrointestinal disorders. Levosulpiride, a selective dopamine D2 receptor antagonist, exhibits prokinetic and antiemetic properties by enhancing gastric motility and facilitating gastric emptying, thereby alleviating symptoms such as nausea, vomiting, bloating, and dyspepsia.
Read full descriptionShow less
Esomeprazole, a proton pump inhibitor, suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system in gastric parietal cells, providing effective acid control and promoting mucosal healing in conditions like gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcers. The sustained-release (SR) formulation of Izra-L Capsule ensures prolonged therapeutic plasma concentrations, optimizing symptom relief and improving patient compliance through once-daily dosing.
This combination is particularly beneficial in patients with overlapping motility and acid-related disorders, offering a dual mechanism of action that addresses both delayed gastric emptying and acid hypersecretion. Izra-L Capsule SR should be used under medical supervision, with consideration of contraindications such as hypersensitivity to components, and caution in patients with renal or hepatic impairment.
Adverse effects may include headache, dizziness, diarrhea, or abdominal discomfort, and patients should be monitored for any unusual symptoms during therapy.
Dosage & How to Use
How to use Izra-L Capsule SR Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Izra-L Capsule SR is to be taken empty stomach.
Safety Advice
Important precautions
Side effects
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Safety Advice
Alcohol
It is unsafe to consume alcohol with Izra-L Capsule SR.
High Risk
Driving
Izra-L Capsule SR may cause side effects which could affect your ability to drive. Izra-L Capsule SR may cause drowsiness, numbness, or dyskinesias, therefore they should be advised to avoid driving and operations requiring supervision.
Exercise Caution
Liver
Izra-L Capsule SR should be used with caution in patients with severe liver disease. Dose adjustment of Izra-L Capsule SR may be needed. Please consult your doctor.
Regular Checkup
Breastfeeding
Izra-L Capsule SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Consult Doctor
Kidney
There is limited information available on the use of Izra-L Capsule SR in patients with kidney disease. Please consult your doctor. However, limited data suggest a cautious use of this medicine in these patients.
Regular Checkup
Customer Reviews
0 reviews for Izra-L Capsule SR
